Anthem Blue Cross Connecticut Commercial Clinical Policy

SURG.00153 Cardiac Contractility Modulation Therapy Form

Chat with GenHealth to automate any policy or prior auth task.

Procedure is not covered

Effective Date

09/27/2023

Last Reviewed

08/10/2023

Original Document

Reference

This document addresses the use of cardiac contractility modulation therapy designed to treat chronic moderate-to-severe heart failure.

Note: Please see the following related document for additional information:

CG-SURG-63 Cardiac Resynchronization Therapy with or without an Implantable Cardioverter Defibrillator for the Treatment of Heart Failure

Position Statement

Investigational and Not Medically Necessary:

The use of cardiac contractility modulation therapy is considered investigational and not medically necessary for all indications, including but not limited to heart failure.

Book a walkthrough

Walk through this policy with us

Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.

GenHealth is the best way to run RCM including eligibility, prior auth, billing, and denials with AI that works like a teammate in your EMR and billing systems.

SURG.00153 Cardiac Contractility Modulation Therapy Form

Procedure is not covered

Position Statement

Walk through this policy with us

Choose how you'd like to learn more.

GenHealth is the best way to run RCM including eligibility, prior auth, billing, and denials with AI that works like a teammate in your EMR and billing systems.

SURG.00153 Cardiac Contractility Modulation Therapy Form

Procedure is not covered

Position Statement

Walk through this policy with us

Choose how you'd like to learn more.

Try GenHealth free.

Automate intake, eligibility, and PA with AI agents that work in your EMR and billing systems.